Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening
This study has been completed.
Sponsor:
University of Turin, Italy
Collaborator:
Agnelli Hospital, Italy
Information provided by:
University of Turin, Italy
ClinicalTrials.gov Identifier:
NCT00482560
First received: June 4, 2007
Last updated: June 28, 2007
Last verified: June 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to compare the antinociceptive effect of 1 ml of 30% sucrose solution vs breastfeeding on neonatal screening heel lance
| Condition | Intervention | Phase |
|---|---|---|
|
Pain |
Drug: Sucrose solution 30%1 ml Behavioral: Breastfeeding |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening |
Resource links provided by NLM:
Further study details as provided by University of Turin, Italy:
Primary Outcome Measures:
- Premature Infant Pain Profile (PIPP) scale rate (0-21) [ Time Frame: 15 seconds before and Within 30 seconds after heel lance ]
Secondary Outcome Measures:
- Heart Rate Increase [ Time Frame: within 30 seconds after heel lance ]
- Oxygen Saturation decrease [ Time Frame: within 30 seconds after heel lance ]
- Duration of first cry [ Time Frame: within 2 minutes after heel lance ]
- Percentage of crying time [ Time Frame: within 2 minutes after heel lance ]
- Percentage of crying time [ Time Frame: During blood sampling ]
| Enrollment: | 100 |
| Study Start Date: | January 2007 |
| Study Completion Date: | April 2007 |
Show Detailed Description
Eligibility| Ages Eligible for Study: | up to 5 Days |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Term neonates, gestational age 37-42 weeks
- Apgar >= 7
- Not fed in the last 30 minutes
- Informant consent
Exclusion Criteria:
- Congenital malformation
- Born in Caesarian Section in General Anaesthesia
- Maternal use of opioids
- Administration of Naloxone, Phenobarbital in the previous 48 hours
- Impossibility of breastfeeding
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00482560
Locations
| Italy | |
| Agnelli Hospital ASL 10 | |
| Pinerolo, Torino, Italy, 10064 | |
Sponsors and Collaborators
University of Turin, Italy
Agnelli Hospital, Italy
Investigators
| Principal Investigator: | Luigi Codipietro, MD | University of Turin Department of Paediatric Science Doctorate in Experimental Pediatry |
| Study Chair: | Alberto Ponzone, MD | University of Turin Department of Paediatric Science Doctorate in Experimental Pediatry |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT00482560 History of Changes |
| Other Study ID Numbers: | PRN19341 |
| Study First Received: | June 4, 2007 |
| Last Updated: | June 28, 2007 |
| Health Authority: | Italy: Ministry of Health |
Keywords provided by University of Turin, Italy:
|
Sucrose Breastfeeding Heel lance |
Additional relevant MeSH terms:
|
Analgesics Sensory System Agents Peripheral Nervous System Agents Physiological Effects of Drugs |
Pharmacologic Actions Central Nervous System Agents Therapeutic Uses |
ClinicalTrials.gov processed this record on May 16, 2013